• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与近期指南更新

Nonalcoholic Fatty Liver Disease and Recent Guideline Updates.

作者信息

Ando Yumi, Jou Janice H

机构信息

Division of Gastroenterology and Hepatology Department of Medicine Oregon Health & Science University Hospital Portland OR.

Division of Gastroenterology and Hepatology Department of Medicine Portland VA Medical Center Portland OR.

出版信息

Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):23-28. doi: 10.1002/cld.1045. eCollection 2021 Jan.

DOI:10.1002/cld.1045
PMID:33552482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7849298/
Abstract

Watch a video presentation of this article.

摘要

观看本文的视频演示。

相似文献

1
Nonalcoholic Fatty Liver Disease and Recent Guideline Updates.非酒精性脂肪性肝病与近期指南更新
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):23-28. doi: 10.1002/cld.1045. eCollection 2021 Jan.
2
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.非酒精性脂肪性肝病与心血管疾病
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):19-22. doi: 10.1002/cld.1017. eCollection 2021 Jan.
3
Spotlight on Impactful Research: Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.聚焦有影响力的研究：相对骨骼肌质量与非酒精性脂肪性肝病之间的关系：一项为期7年的纵向研究。
Clin Liver Dis (Hoboken). 2020 Jun 30;15(6):213-214. doi: 10.1002/cld.914. eCollection 2020 Jun.
4
Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.基层医疗医生和专科医生对非酒精性脂肪性肝炎的认知及相关实践模式
BMC Res Notes. 2016 Mar 11;9:157. doi: 10.1186/s13104-016-1946-1.
5
Nonalcoholic fatty liver disease in the pediatric population: a review.儿科人群中的非酒精性脂肪性肝病：综述
Curr Opin Pediatr. 2005 Oct;17(5):636-41. doi: 10.1097/01.mop.0000172816.79637.c5.
6
Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation.非酒精性脂肪性肝炎、肌肉减少症与肝移植
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):2-5. doi: 10.1002/cld.1000. eCollection 2021 Jan.
7
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.慢性肾脏病与非酒精性脂肪性肝病患者的死亡率增加独立相关。
Liver Int. 2019 Feb;39(2):342-352. doi: 10.1111/liv.13992. Epub 2018 Dec 4.
8
Nonalcoholic fatty liver disease remission in men through regular exercise.男性通过规律运动实现非酒精性脂肪性肝病缓解
J Clin Biochem Nutr. 2018 May;62(3):242-246. doi: 10.3164/jcbn.17-115. Epub 2018 Mar 17.
9
Fatty liver and the metabolic syndrome.脂肪肝与代谢综合征
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8. doi: 10.1097/MOG.0b013e32801421a9.
10
Treatment of nonalcoholic fatty liver: present and emerging therapies.非酒精性脂肪性肝病的治疗：当前及新兴疗法
Semin Liver Dis. 2001;21(1):81-8. doi: 10.1055/s-2001-12931.

引用本文的文献

1
From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood.从儿童肥胖到儿童期氧化应激导致的代谢功能障碍相关脂肪性肝病（MASLD）和高脂血症。
Metabolites. 2025 Apr 24;15(5):287. doi: 10.3390/metabo15050287.
2
Increased Hepatorenal Index Is Associated with the Risk of Developing Stroke in Patients with Nonalcoholic Fatty Liver Disease.肝肾指数升高与非酒精性脂肪性肝病患者发生中风的风险相关。
Curr Med Sci. 2025 May 7. doi: 10.1007/s11596-025-00051-1.
3
Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: a systematic review and meta-analysis.身体圆润度指数预测非酒精性脂肪性肝病的有效性：一项系统评价和荟萃分析
Lipids Health Dis. 2025 Mar 27;24(1):117. doi: 10.1186/s12944-025-02544-3.
4
Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver.肝脏中的胰岛素抵抗（IR）和胰岛素样生长因子1受体（IGF1R）信号传导在肝脏中PTEN缺乏时调控不同的代谢和致癌过程。
JHEP Rep. 2024 Dec 19;7(4):101305. doi: 10.1016/j.jhepr.2024.101305. eCollection 2025 Apr.
5
The effect of replacing grains with quinoa on cardiometabolic risk factors and liver function in patients with non-alcoholic fatty liver: a randomized-controlled clinical trial.用藜麦替代谷物对非酒精性脂肪肝患者心脏代谢危险因素和肝功能的影响：一项随机对照临床试验。
Front Nutr. 2025 Mar 3;12:1505183. doi: 10.3389/fnut.2025.1505183. eCollection 2025.
6
Negative association of composite dietary antioxidant index with risk of hepatic fibrosis in individuals underwent cholecystectomy: a cross-sectional study.胆囊切除术后个体复合膳食抗氧化指数与肝纤维化风险的负相关：一项横断面研究
Sci Rep. 2025 Mar 16;15(1):9040. doi: 10.1038/s41598-025-93782-z.
7
Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review.2型糖尿病患者代谢功能障碍相关脂肪性肝病的药物治疗选择：一项系统评价
Eur J Clin Invest. 2025 Apr;55(4):e70003. doi: 10.1111/eci.70003. Epub 2025 Feb 12.
8
Design and rationale for a global novel non-invasive screening observational study using genetics and non-invasive methodologies to identify at-risk MASLD participants: The ALIGN study.一项利用遗传学和非侵入性方法识别高危非酒精性脂肪性肝病（MASLD）参与者的全球新型非侵入性筛查观察性研究的设计与原理：ALIGN研究
Contemp Clin Trials Commun. 2025 Jan 20;44:101437. doi: 10.1016/j.conctc.2025.101437. eCollection 2025 Apr.
9
Prevalence and Predictors for Lean Fatty Liver Disease in General Population Attending a COVID-19 Vaccination Center in a Tertiary Care Hospital in India.印度一家三级护理医院新冠疫苗接种中心普通人群中瘦型非酒精性脂肪性肝病的患病率及预测因素
Euroasian J Hepatogastroenterol. 2024 Jul-Dec;14(2):145-150. doi: 10.5005/jp-journals-10018-1438. Epub 2024 Dec 27.
10
Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction-associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways.恩格列净和维生素 D 双重疗法通过增强代谢、氧化应激和炎症途径的调节，增强对代谢功能障碍相关脂肪性肝炎的肝保护作用。
Int J Exp Pathol. 2024 Dec;105(6):219-234. doi: 10.1111/iep.12519. Epub 2024 Oct 13.

本文引用的文献

1
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
2
Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis.代谢合并症的增加与非酒精性脂肪性肝炎中晚期纤维化的风险增加相关。
PLoS One. 2019 Aug 1;14(8):e0220612. doi: 10.1371/journal.pone.0220612. eCollection 2019.
3
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease.真实世界的数据揭示了非酒精性脂肪性肝病诊断方面的差距。
BMC Med. 2018 Aug 13;16(1):130. doi: 10.1186/s12916-018-1103-x.
4
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
5
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.《2017年亚太地区非酒精性脂肪性肝病工作组指南 - 第2部分：管理与特殊群体》
J Gastroenterol Hepatol. 2018 Jan;33(1):86-98. doi: 10.1111/jgh.13856.
6
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.2017年亚太地区非酒精性脂肪性肝病工作小组指南 - 第1部分：定义、危险因素及评估
J Gastroenterol Hepatol. 2018 Jan;33(1):70-85. doi: 10.1111/jgh.13857.
7
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.非酒精性脂肪性肝病与心血管疾病发病风险：荟萃分析。
J Hepatol. 2016 Sep;65(3):589-600. doi: 10.1016/j.jhep.2016.05.013. Epub 2016 May 17.
8
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004. Epub 2016 Apr 7.
9
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.美国退伍军人中无肝硬化的肝细胞癌与非酒精性脂肪性肝病相关。
Clin Gastroenterol Hepatol. 2016 Jan;14(1):124-31.e1. doi: 10.1016/j.cgh.2015.07.019. Epub 2015 Jul 18.
10
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.肝纤维化而非其他组织学特征与非酒精性脂肪性肝病患者的长期预后相关。
Gastroenterology. 2015 Aug;149(2):389-97.e10. doi: 10.1053/j.gastro.2015.04.043. Epub 2015 Apr 29.